Heidelberg Pharma AG's total assets for Q4 2025 were €38.14M, an increase of 23.91% from the previous quarter. DE:HPHA total liabilities were €49.05M for the fiscal quarter, a 6.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.